Laformin GV 1mg/500mg/0.2mg Tablet ER
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Laformin GV 1mg/500mg/0.2mg Tablet ER
GlycemaControl ER 1mg/500mg/0.2mg tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This medication helps regulate blood glucose. GlycemaControl ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests, may be recommended.
Uses of Laformin GV 1mg/500mg/0.2mg Tablet ER
Managing type 2 diabetes
Major Benefits of Laformin GV 1mg/500mg/0.2mg Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Laformin GV 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
Common Side effects of Laformin GV 1mg/500mg/0.2mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Laformin GV 1mg/500mg/0.2mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Laformin GV 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Laformin GV 1mg/500mg/0.2mg Tablet ER works:
Extended-release Laformin GV tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Laformin GV 1mg/500mg/0.2mg Tablet ER is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Laformin GV 1mg/500mg/0.2mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Laformin GV tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Patients with kidney disease should likely avoid Laformin GV 1mg/500mg/0.2mg Tablet ER, as its use may be unsafe. Medical advice is recommended. The use of Laformin GV 1mg/500mg/0.2mg Tablet ER is contraindicated in those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Laformin GV 1mg/500mg/0.2mg Extended-Release Tablets cautiously. Dosage modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a reduced Laformin GV 1mg/500mg/0.2mg Extended-Release Tablet dose is typical; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Laformin GV 1mg/500mg/0.2mg Tablet ER :
Should you forget a Laformin GV 1mg/500mg/0.2mg Extended-Release tablet, take it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Laformin GV 1mg/500mg/0.2mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently